• LY-411575: Gamma-Secretase Inhibitor for Advanced Assay Desi

  2026-06-02

  LY-411575 excels as a highly potent gamma-secretase inhibitor for dissecting amyloid beta production and Notch pathway signaling. This article delivers actionable workflows, troubleshooting guidance, and comparative insights that empower Alzheimer's and cancer research teams to maximize reproducibility and interpretability with APExBIO’s reference-grade compound.

• S Tag Peptide: Technical Guide for Fusion Tag Applications

  2026-06-02

  S Tag Peptide (SKU A6007) addresses challenges in recombinant protein detection, purification, and solubility enhancement by serving as a reliable fusion tag. It is best suited for workflows requiring high solubility and specific affinity purification or detection using anti-S-Tag antibodies. It is not recommended where ethanol solubility or long-term aqueous storage is required, or for applications dependent on intrinsic enzymatic activity of the tag alone.

• Z-WEHD-FMK: Optimizing Caspase-1 Inhibition in Inflammation

  2026-06-01

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) delivers precise, irreversible blockade of inflammatory caspases, empowering advanced dissection of apoptosis and pyroptosis. Its use in infectious disease and cell signaling studies reveals unique advantages for uncovering pathogen-host interactions and fine-tuning cell death assays.

• Morin Enhances Mitochondrial Energy Assays & Podocyte Models

  2026-06-01

  Morin, a natural flavonoid antioxidant, elevates podocyte injury and mitochondrial energy workflows by targeting AMPD2 activity and serving as a fluorescent aluminum ion probe. Optimized for high-purity, reproducibility, and advanced disease modeling, Morin from APExBIO sets a new benchmark for translational kidney and metabolic research.

• CasKAS Enables Rapid Genome-wide Profiling of CRISPR Specifi

  2026-05-31

  CasKAS is a novel assay that directly maps dCas9 and Cas9 specificity genome-wide by detecting single-stranded DNA associated with CRISPR binding. This approach offers a faster, cost-effective alternative to existing methods, enhancing the accuracy and accessibility of CRISPR off-target profiling in both research and translational settings.

• RNA Pol II Degradation Triggers Apoptosis Independent of Tra

  2026-05-30

  Harper et al. reveal that loss of RNA Pol IIA, rather than transcriptional shutdown, activates a regulated apoptotic response via mitochondrial signaling. This paradigm shift uncovers the Pol II degradation-dependent apoptotic response (PDAR), with broad implications for understanding and targeting cell death in cancer biology and apoptosis assays.

• Genistein (A2198): Precision Inhibitor for Cell Proliferatio

  2026-05-29

  This in-depth article guides biomedical researchers and lab technicians through real-world challenges in cell viability, proliferation, and cytotoxicity assays. Using scenario-driven Q&A, it demonstrates how Genistein (SKU A2198) delivers reproducible, data-backed solutions for mechanotransduction and cancer chemoprevention studies. Practical protocol parameters, scientific context, and vendor reliability are addressed to empower optimal experimental design.

• FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone): D

  2026-05-29

  This article addresses practical challenges in cell viability, proliferation, and cytotoxicity assays by exploring the use of FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), specifically SKU B5004. Drawing on validated protocols and current literature, we provide scenario-driven guidance for biomedical researchers seeking reproducible, quantitative data in mitochondrial and metabolic regulation studies.

• Propranolol’s Role in Disrupting Emotional Memory Consolidat

  2026-05-28

  This meta-analysis systematically evaluates propranolol’s effects on the formation and reconsolidation of long-term emotional memories in healthy adults. The findings highlight moderate reductions in recall for negative material, providing mechanistic insight relevant to both basic research and novel psychiatric interventions.

• Vorinostat (SAHA): Epigenetic Precision in Tumor Modeling

  2026-05-28

  Explore how Vorinostat, a powerful histone deacetylase inhibitor, enables advanced epigenetic modulation in cancer biology research. This article uncovers new insights for protocol design and translational assay development.

• Distinct Mechanisms of Gepotidacin and Fluoroquinolones on S

  2026-05-27

  Gibson et al. provide mechanistic and structural insights into the antibacterial gepotidacin, revealing how it inhibits Staphylococcus aureus gyrase via unique single-stranded DNA break induction, contrasting fluoroquinolone antibiotics such as Moxifloxacin. These findings clarify resistance pathways and inform the rational design of next-generation gyrase inhibitors.

• Homoharringtonine: Cytotoxic Alkaloid for Cancer and SARS-Co

  2026-05-27

  Homoharringtonine, a cytotoxic alkaloid from Cephalotaxus hainanensis, inhibits eukaryotic protein synthesis via 80S ribosome binding. It is validated for leukemia research and demonstrates rapid SARS-CoV-2 clearance in vivo. The product is available from APExBIO and is intended solely for research use.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome: Cli

  2026-05-26

  This article analyzes a recent case report detailing the presentation, diagnostic challenges, and management of neuroleptic malignant syndrome (NMS) induced by prochlorperazine in an elderly patient. The findings emphasize the necessity of early recognition and tailored interventions for NMS, particularly when laboratory abnormalities are absent, and contextualize these insights with related mechanisms in neurodegenerative and metabolic research.

• Rifampin in Research: Protocols, Applications & Troubleshoot

  2026-05-26

  Rifampin, a gold-standard rifamycin antibiotic, enables precise and reproducible transcriptional inhibition in bacterial resistance and synthetic biology workflows. This article delivers stepwise protocols, advanced troubleshooting, and actionable insights—empowering scientists to unlock the full potential of APExBIO’s Rifampin for cutting-edge experimental applications.

• SHC-1 Inhibition Regulates CFTR Membrane Abundance in Epithe

  2026-05-25

  This study systematically investigates how SHC-1 inhibition affects the plasma membrane localization of the cystic fibrosis transmembrane conductance regulator (CFTR) channel across various epithelial cell models. By mapping the MAPK/SHC-1 signaling pathway’s role in CFTR internalization, the research refines understanding of CFTR trafficking and highlights important cell-type-specific regulatory mechanisms relevant for cystic fibrosis and secretory epithelial diseases.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page